Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | LY3009120 |
| Trade Name | |
| Synonyms | DP-4978 |
| Drug Descriptions |
LY3009120 is a Pan-RAF inhibitor that inhibits signaling of all RAF isoforms and RAF dimers, which leads to inhibition of tumor cell growth (PMID: 26343583, PMID: 28576749). |
| DrugClasses | RAF Inhibitor (Pan) 29 |
| CAS Registry Number | 1454682-72-4 |
| NCIT ID | C116861 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| LY3009120 | LY3009120 | 28 | 1 |
| LY3009120 + LY3214996 | LY3009120 LY3214996 | 3 | 0 |
| LY3009120 + Osimertinib | LY3009120 Osimertinib | 0 | 0 |
| LY3009120 + Trametinib | LY3009120 Trametinib | 4 | 0 |
| LY3009120 + Vemurafenib | LY3009120 Vemurafenib | 1 | 0 |